What is Spondyloepiphyseal Dysplasia Tarda

Spondyloepiphyseal dysplasia tarda (SEDT) is a rare genetic bone disorder characterized by the delayed onset of skeletal abnormalities, specifically affecting the spine (spondylo-) and the ends of the long bones (-epiphyseal). It results in disproportionate short stature and premature osteoarthritis, often becoming clinically apparent during late childhood or adolescence.

What causes Spondyloepiphyseal dysplasia tarda?

Spondyloepiphyseal dysplasia tarda is primarily caused by mutations in the TRAPPC2 gene, which is located on the X chromosome. Because it is an X-linked recessive condition, it predominantly affects males. The underlying mechanism involves a defect in the transport of proteins within cartilage cells, which impairs the normal development and maintenance of the bone matrix, leading to the characteristic skeletal changes seen in Spondyloepiphyseal dysplasia tarda.

How does Spondyloepiphyseal dysplasia tarda affect the body?

The clinical presentation of Spondyloepiphyseal dysplasia tarda involves specific skeletal features that typically manifest between the ages of 5 and 10. Key physical characteristics include:

• Progressive shortening of the trunk resulting in disproportionate short stature.


• Flattening of the vertebral bodies (platyspondyly) with a characteristic "hump" at the back of the vertebrae.


• Early-onset, degenerative joint disease, particularly in the hips, knees, and shoulders.


• A barrel-chested appearance and a tendency toward a stiff, waddling gait as joint pain develops.

How common is Spondyloepiphyseal dysplasia tarda?

Spondyloepiphyseal dysplasia tarda is an extremely rare condition with a prevalence estimated at approximately 1 in 600,000 individuals. While it is rare, the DiseaseMaps.org community currently supports 11 individuals living with this condition, providing a space for shared experiences and peer support.

What differentiates this condition from other dysplasias?

Unlike other forms of skeletal dysplasia that are present at birth (congenital), Spondyloepiphyseal dysplasia tarda is defined by its "tarda" or late-onset nature. While other conditions like achondroplasia affect limbs primarily, Spondyloepiphyseal dysplasia tarda focuses its impact on the spine and the epiphyses of long bones, often sparing intellectual development, which remains normal in these patients.

Next steps

• Consult a medical geneticist for definitive diagnosis via molecular genetic testing.


• Schedule regular evaluations with a pediatric orthopedist to manage joint health and monitor spinal curvature.


• Connect with the 11 community members on DiseaseMaps.org to share resources and coping strategies.


• Discuss physical therapy options with your specialist to maintain joint mobility and manage chronic pain.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment from a qualified physician.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Spondyloepiphyseal dysplasia tarda.


• Orphanet: X-linked spondyloepiphyseal dysplasia tarda (ORPHA:3337).


• OMIM (Online Mendelian Inheritance in Man): Spondyloepiphyseal dysplasia tarda; SEDT (#313400).


• DiseaseMaps.org: Community insights and patient-led data.